Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Nov;94(2):354–362. doi: 10.1111/j.1365-2249.1993.tb03457.x

Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.

M Kristensen 1, C Q Chu 1, D J Eedy 1, M Feldmann 1, F M Brennan 1, S M Breathnach 1
PMCID: PMC1534247  PMID: 8222328

Abstract

The distribution of TNF-alpha, p55 TNF receptor (TNF-R) and p75 TNF-R in normal skin and uninvolved and lesional skin from psoriasis patients has been investigated, using specific mono- and polyclonal antibodies. In normal skin, and uninvolved and lesional skin from psoriasis patients, p55 TNF-R is associated with epidermal keratinocytes and a network of upper dermal dendritic cells. This suggests that the actions of TNF-alpha on epidermal cells in vivo are mediated by binding to the p55 TNF-R. In lesional psoriasis skin, there was staining of the parakeratotic stratum corneum and increased expression of p55 TNF-R in association with upper dermal blood vessels. Staining for p75 TNF-R in normal skin was restricted to eccrine sweat ducts and dermal dendritic cells, and was absent from the epidermis. In lesional psoriasis skin, there was staining for p75 TNF-R in association with upper dermal blood vessels and perivascular infiltrating cells. TNF-alpha in normal skin was predominantly localized to the basal cell layers of the epidermis, and was seen in association with eccrine ducts and sebaceous glands. In lesional psoriasis skin, and to a lesser extent in uninvolved psoriasis skin, TNF-alpha was distributed throughout the epidermis, and was also specifically localized to upper dermal blood vessels. Up-regulation of TNF-alpha, p55 TNF-R and p75 TNF-R on dermal blood vessels in psoriasis may play an important role in the pathogenesis of this condition by promoting cutaneous recruitment of inflammatory cells.

Full text

PDF
354

Images in this article

358Fig. 4
on p.358
358Fig. 5
on p.358
355Fig. 1
on p.355
356Fig. 2
on p.356
356Fig. 3
on p.356
359Fig. 6
on p.359
359Fig. 7
on p.359
360Fig. 8
on p.360

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adolf G. R., Frühbeis B. Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity. Cytokine. 1992 May;4(3):180–184. doi: 10.1016/1043-4666(92)90053-t. [DOI] [PubMed] [Google Scholar]
  2. Barker J. N., Karabin G. D., Stoof T. J., Sarma V. J., Dixit V. M., Nickoloff B. J. Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci. 1991 Mar;2(2):106–111. doi: 10.1016/0923-1811(91)90019-t. [DOI] [PubMed] [Google Scholar]
  3. Barker J. N., Mitra R. S., Griffiths C. E., Dixit V. M., Nickoloff B. J. Keratinocytes as initiators of inflammation. Lancet. 1991 Jan 26;337(8735):211–214. doi: 10.1016/0140-6736(91)92168-2. [DOI] [PubMed] [Google Scholar]
  4. Beutler B. A., Milsark I. W., Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol. 1985 Dec;135(6):3972–3977. [PubMed] [Google Scholar]
  5. Brockhaus M., Schoenfeld H. J., Schlaeger E. J., Hunziker W., Lesslauer W., Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3127–3131. doi: 10.1073/pnas.87.8.3127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cai J. P., Falanga V., Chin Y. H. Transforming growth factor-beta regulates the adhesive interactions between mononuclear cells and microvascular endothelium. J Invest Dermatol. 1991 Aug;97(2):169–174. doi: 10.1111/1523-1747.ep12479498. [DOI] [PubMed] [Google Scholar]
  7. Chu C. Q., Field M., Feldmann M., Maini R. N. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Sep;34(9):1125–1132. doi: 10.1002/art.1780340908. [DOI] [PubMed] [Google Scholar]
  8. Creaven P. J., Stoll H. L., Jr Response to tumor necrosis factor in two cases of psoriasis. J Am Acad Dermatol. 1991 May;24(5 Pt 1):735–737. doi: 10.1016/0190-9622(91)70112-f. [DOI] [PubMed] [Google Scholar]
  9. Cua A. B., Wilhelm K. P., Maibach H. I. Elastic properties of human skin: relation to age, sex, and anatomical region. Arch Dermatol Res. 1990;282(5):283–288. doi: 10.1007/BF00375720. [DOI] [PubMed] [Google Scholar]
  10. Deleuran B. W., Chu C. Q., Field M., Brennan F. M., Mitchell T., Feldmann M., Maini R. N. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum. 1992 Oct;35(10):1170–1178. doi: 10.1002/art.1780351009. [DOI] [PubMed] [Google Scholar]
  11. Dembic Z., Loetscher H., Gubler U., Pan Y. C., Lahm H. W., Gentz R., Brockhaus M., Lesslauer W. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine. 1990 Jul;2(4):231–237. doi: 10.1016/1043-4666(90)90022-l. [DOI] [PubMed] [Google Scholar]
  12. Erikstein B. K., Smeland E. B., Blomhoff H. K., Funderud S., Prydz K., Lesslauer W., Espevik T. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol. 1991 Apr;21(4):1033–1037. doi: 10.1002/eji.1830210426. [DOI] [PubMed] [Google Scholar]
  13. Espevik T., Brockhaus M., Loetscher H., Nonstad U., Shalaby R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med. 1990 Feb 1;171(2):415–426. doi: 10.1084/jem.171.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991 Jul 22;285(2):199–212. doi: 10.1016/0014-5793(91)80803-b. [DOI] [PubMed] [Google Scholar]
  15. Gearing A. J., Fincham N. J., Bird C. R., Wadhwa M., Meager A., Cartwright J. E., Camp R. D. Cytokines in skin lesions of psoriasis. Cytokine. 1990 Jan;2(1):68–75. doi: 10.1016/1043-4666(90)90045-u. [DOI] [PubMed] [Google Scholar]
  16. Gomi T., Shiohara T., Munakata T., Imanishi K., Nagashima M. Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis. Arch Dermatol. 1991 Jun;127(6):827–830. [PubMed] [Google Scholar]
  17. Gray P. W., Barrett K., Chantry D., Turner M., Feldmann M. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7380–7384. doi: 10.1073/pnas.87.19.7380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Griffiths C. E., Barker J. N., Kunkel S., Nickoloff B. J. Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol. 1991 Jun;124(6):519–526. doi: 10.1111/j.1365-2133.1991.tb04943.x. [DOI] [PubMed] [Google Scholar]
  19. Griffiths C. E., Voorhees J. J., Nickoloff B. J. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol. 1989 Apr;20(4):617–629. doi: 10.1016/s0190-9622(89)70073-6. [DOI] [PubMed] [Google Scholar]
  20. Ikuta S., Kirby J. A., Shenton B. K., Givan A. L., Lennard T. W. Human endothelial cells: effect of TNF-alpha on peripheral blood mononuclear cell adhesion. Immunology. 1991 May;73(1):71–76. [PMC free article] [PubMed] [Google Scholar]
  21. Köck A., Schwarz T., Kirnbauer R., Urbanski A., Perry P., Ansel J. C., Luger T. A. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 1990 Dec 1;172(6):1609–1614. doi: 10.1084/jem.172.6.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Larsen C. G., Anderson A. O., Oppenheim J. J., Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology. 1989 Sep;68(1):31–36. [PMC free article] [PubMed] [Google Scholar]
  23. Loetscher H., Pan Y. C., Lahm H. W., Gentz R., Brockhaus M., Tabuchi H., Lesslauer W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 1990 Apr 20;61(2):351–359. doi: 10.1016/0092-8674(90)90815-v. [DOI] [PubMed] [Google Scholar]
  24. Nagano K., Hori K., Nagane T., Sugawara T., Oh-ishi J., Hayashi H., Watanabe N., Niitsu Y. Effect of tumour necrosis factor in the mouse-tail model of psoriasis. Arch Dermatol Res. 1990;282(7):459–462. doi: 10.1007/BF00402623. [DOI] [PubMed] [Google Scholar]
  25. Nickoloff B. J., Karabin G. D., Barker J. N., Griffiths C. E., Sarma V., Mitra R. S., Elder J. T., Kunkel S. L., Dixit V. M. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol. 1991 Jan;138(1):129–140. [PMC free article] [PubMed] [Google Scholar]
  26. Oxholm A., Oxholm P., Staberg B., Bendtzen K. Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br J Dermatol. 1988 Mar;118(3):369–376. doi: 10.1111/j.1365-2133.1988.tb02430.x. [DOI] [PubMed] [Google Scholar]
  27. Partridge M., Chantry D., Turner M., Feldmann M. Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines. J Invest Dermatol. 1991 May;96(5):771–776. doi: 10.1111/1523-1747.ep12471723. [DOI] [PubMed] [Google Scholar]
  28. Piguet P. F., Grau G. E., Hauser C., Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med. 1991 Mar 1;173(3):673–679. doi: 10.1084/jem.173.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Piguet P. F., Grau G. E., Vassalli P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am J Pathol. 1990 Jan;136(1):103–110. [PMC free article] [PubMed] [Google Scholar]
  30. Ryffel B., Brockhaus M., Greiner B., Mihatsch M. J., Gudat F. Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology. 1991 Nov;74(3):446–452. [PMC free article] [PubMed] [Google Scholar]
  31. Schall T. J., Lewis M., Koller K. J., Lee A., Rice G. C., Wong G. H., Gatanaga T., Granger G. A., Lentz R., Raab H. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 1990 Apr 20;61(2):361–370. doi: 10.1016/0092-8674(90)90816-w. [DOI] [PubMed] [Google Scholar]
  32. Strieter R. M., Kunkel S. L., Showell H. J., Remick D. G., Phan S. H., Ward P. A., Marks R. M. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science. 1989 Mar 17;243(4897):1467–1469. doi: 10.1126/science.2648570. [DOI] [PubMed] [Google Scholar]
  33. Swerlick R. A., Garcia-Gonzalez E., Kubota Y., Xu Y. L., Lawley T. J. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol. 1991 Aug;97(2):190–196. doi: 10.1111/1523-1747.ep12479643. [DOI] [PubMed] [Google Scholar]
  34. Takematsu H., Ohta H., Tagami H. Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis. Arch Dermatol Res. 1989;281(6):398–400. doi: 10.1007/BF00455324. [DOI] [PubMed] [Google Scholar]
  35. Takematsu H., Ozawa H., Yoshimura T., Hara M., Sakakibara A., Oyama J., Tagami H. Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasis. Br J Dermatol. 1991 Feb;124(2):209–210. doi: 10.1111/j.1365-2133.1991.tb00439.x. [DOI] [PubMed] [Google Scholar]
  36. Trefzer U., Brockhaus M., Loetscher H., Parlow F., Kapp A., Schöpf E., Krutmann J. 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J Invest Dermatol. 1991 Nov;97(5):911–916. doi: 10.1111/1523-1747.ep12491668. [DOI] [PubMed] [Google Scholar]
  37. Wakefield P. E., James W. D., Samlaska C. P., Meltzer M. S. Tumor necrosis factor. J Am Acad Dermatol. 1991 May;24(5 Pt 1):675–685. doi: 10.1016/0190-9622(91)70102-8. [DOI] [PubMed] [Google Scholar]
  38. Walsh L. J., Trinchieri G., Waldorf H. A., Whitaker D., Murphy G. F. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4220–4224. doi: 10.1073/pnas.88.10.4220. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES